Micrornas in Cancer

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Micrornas in Cancer Publisher

Mirzaei H¹ ; Rahimian N² ; Mirzaei HR³ ; Nahand JS⁴ ; Hamblin MR⁵

Source: Synthesis Lectures on Biomedical Engineering Published:2022

Abstract

The dysregulation of microRNAs in cancer was first reported in 2002, when a cluster of two microRNAs (miR16 and miR-15) was detected at chromosome 13q14.3, which had been proposed as one of the commonly eliminated genetic regions in chronic lymphocytic leukemia (CLL) patients [1]. The deletion of this miRNA cluster acts (at least partly) by increasing the expression level of the specific target of miR-15/16, which is the anti-apoptotic protein B cell lymphoma 2 (BCL2). It has been found that micro-RNAs can contribute to each cancer hallmark described by Hanahan and Weinberg [2], as well affecting the clinical progression of many cancers at different stages. © 2022, Springer Nature Switzerland AG.

Related Docs

View other Related Docs

1. Exosomes and Micrornas in Biomedical Science, Synthesis Lectures on Biomedical Engineering (2022)

2. Cancer Genetics at a Glance: The Comprehensive Insights, Cancer Genetics and Psychotherapy (2017)

3. The Microrna Let-7 and Its Exosomal Form: Epigenetic Regulators of Gynecological Cancers, Cell Biology and Toxicology (2024)

Experts (# of related papers)

View all Related Experts

Hamid Reza Mirzaei (1)

Mohammad Hossein Modarressi (1)

Other Related Docs

4. A Comprehensive Review on Oncogenic Mirnas in Breast Cancer, Journal of Genetics (2021)

5. The Role of Oncomirs in the Pathogenesis and Treatment of Breast Cancer, Biomedicine and Pharmacotherapy (2016)

6. Micrornas As Biomarkers for Early Diagnosis, Targeting and Prognosis of Prostate Cancer, Pathology Research and Practice (2023)

7. Microrna-Induced Drug Resistance in Gastric Cancer, Biomedicine and Pharmacotherapy (2015)

8. Microrna in Leukemia: Tumor Suppressors and Oncogenes With Prognostic Potential, Journal of Cellular Physiology (2019)

9. Expression of the Circulating and the Tissue Micrornas After Surgery, Chemotherapy, and Radiotherapy in Mice Mammary Tumor, Tumor Biology (2016)

10. Emerging Role of Let-7 Family in the Pathogenesis of Hematological Malignancies, Biomedicine and Pharmacotherapy (2021)

11. Microrna As a Systemic Intervention in the Specific Breast Cancer Subtypes With C-Myc Impacts; Introducing Subtype-Based Appraisal Tool, Journal of Cellular Physiology (2018)

12. Microrna-181 Serves As a Dual-Role Regulator in the Development of Human Cancers, Free Radical Biology and Medicine (2020)

13. Microrna-Related Single-Nucleotide Polymorphisms and Breast Cancer, Journal of Cellular Physiology (2021)

14. Mirna Profiling in Adult T-Cell Leukemia Lymphoma (Atll), a Systems Virology Study, Gene Reports (2021)

15. How Micrornas Affect the Pd-L1 and Its Synthetic Pathway in Cancer, International Immunopharmacology (2020)

16. Inflammation Related Mirnas As an Important Player Between Obesity and Cancers, Journal of Diabetes and Metabolic Disorders (2019)

17. Molecular Mechanisms Underlying Curcumin-Mediated Microrna Regulation in Carcinogenesis; Focused on Gastrointestinal Cancers, Biomedicine and Pharmacotherapy (2021)

18. Dysregulation of Mir-638 in Breast Cancer Patients and Bioinformatics Investigation of Its Target Genes in Apoptosis, Angiogenesis and Autophagy Pathways, International Journal of Cancer Management (2019)

19. Prognostic and Diagnostic Values of Non-Coding Rnas As Biomarkers for Breast Cancer: An Umbrella Review and Pan-Cancer Analysis, Frontiers in Molecular Biosciences (2023)

20. Differential Role of Micrornas in Prognosis, Diagnosis, and Therapy of Ovarian Cancer, Biomedicine and Pharmacotherapy (2016)

Style	Citing Format
MLA	Mirzaei H, et al.. "Micrornas in Cancer." Synthesis Lectures on Biomedical Engineering, vol. , no. , 2022, pp. 11-40.
APA	Mirzaei H, Rahimian N, Mirzaei HR, Nahand JS, Hamblin MR (2022). Micrornas in Cancer. Synthesis Lectures on Biomedical Engineering, (), 11-40.
Chicago	Mirzaei H, Rahimian N, Mirzaei HR, Nahand JS, Hamblin MR. "Micrornas in Cancer." Synthesis Lectures on Biomedical Engineering , no. (2022): 11-40.
Harvard	Mirzaei H et al. (2022) 'Micrornas in Cancer', Synthesis Lectures on Biomedical Engineering, (), pp. 11-40.
Vancouver	Mirzaei H, Rahimian N, Mirzaei HR, Nahand JS, Hamblin MR. Micrornas in Cancer. Synthesis Lectures on Biomedical Engineering. 2022;():11-40.
BibTex	@article{ author = {Mirzaei H and Rahimian N and Mirzaei HR and Nahand JS and Hamblin MR}, title = {Micrornas in Cancer}, journal = {Synthesis Lectures on Biomedical Engineering}, volume = {}, number = {}, pages = {11-40}, year = {2022} }
RIS	TY - JOUR AU - Mirzaei H AU - Rahimian N AU - Mirzaei HR AU - Nahand JS AU - Hamblin MR TI - Micrornas in Cancer JO - Synthesis Lectures on Biomedical Engineering VL - IS - SP - 11 EP - 40 PY - 2022 ER -

Science Communicator Platform

Authors

Abstract